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Abstract
Background: HIV increases the progression of latent tuberculosis (TB) infection to active disease and contributed to
increased TB in the UK until 2004. We describe temporal trends in HIV infection amongst patients with TB and
identify factors associated with HIV infection.
Methods: We used national surveillance data of all TB cases reported in England, Wales and Northern Ireland from
2000 to 2014 and determined HIV status through record linkage to national HIV surveillance. We used logistic
regression to identify associations between HIV and demographic, clinical and social factors.
Results: There were 106,829 cases of TB in adults (≥ 15 years) reported from 2000 to 2014. The number and
proportion of TB patients infected with HIV decreased from 543/6782 (8.0%) in 2004 to 205/6461 (3.2%) in 2014. The
proportion of patients diagnosed with HIV > 91 days prior to their TB diagnosis increased from 33.5% in 2000 to 60.
2% in 2013. HIV infection was highest in people of black African ethnicity from countries with high HIV prevalence
(32.3%), patients who misused drugs (8.1%) and patients with miliary or meningeal TB (17.2%).
Conclusions: There has been an overall decrease in TB-HIV co-infection and a decline in the proportion of patients
diagnosed simultaneously with both infections. However, high rates of HIV remain in some sub-populations of
patients with TB, particularly black Africans born in countries with high HIV prevalence and people with a history of
drug misuse. Whilst the current policy of testing all patients diagnosed with TB for HIV infection is important in
ensuring appropriate management of TB patients, many of these TB cases would be preventable if HIV could be
diagnosed before TB develops. Improving screening for both latent TB and HIV and ensuring early treatment of HIV
in these populations could help prevent these TB cases. British HIV Association guidelines on latent TB testing for
people with HIV from sub-Saharan Africa remain relevant, and latent TB screening for people with HIV with a history
of drug misuse, homelessness or imprisonment should also be considered.
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Background
Tuberculosis (TB) cases reported in England and Wales
increased from 2000 to 2011, peaking at 8280 cases
(15.6/100,000 population), but then declined by a third
between 2011 and 2015 [1]. Nevertheless, these rates re-
main amongst the highest in western Europe.
The number of people living with HIV (PLHIV) in the
UK increased by 10% from 2010 to more than 100,000
in 2015, although new diagnoses have remained rela-
tively constant [2]. HIV co-infection contributed sub-
stantially to the rise in TB from 1999 to 2003; 31% of
the increase in TB was in people with HIV, and by 2003
the prevalence of HIV was 8.3% [3]. However, HIV
prevalence amongst patients with TB decreased to 3.2%
by 2014 [1]. Between 2002 and 2010, more than 50% of
TB-HIV co-infections in heterosexual PLHIV were diag-
nosed simultaneously (within 91 days) [4]. The epidemi-
ology of both TB and HIV in the UK have changed over
the last decade; migration from sub-Saharan Africa has
decreased since the mid-2000s, whilst migration from
Asia and eastern Europe has increased [5, 6], leading to
fewer new HIV infections in individuals of black African
ethnicity [4] and more TB in patients from the Indian
sub-continent and eastern Europe [1]. However, trends
in TB-HIV epidemiology have not been recently
described.
Social risk factors are also a concern in TB-HIV epi-
demiology. The proportion of TB patients in England
with such risk factors (particularly drug misuse, home-
lessness and imprisonment) rose from 9.8% in 2010 to
12% in 2015, although the numbers remained relatively
constant [1]. Tackling TB in under-served populations is
one of the key areas for action in the 2015–2020 Collab-
orative tuberculosis strategy for England [7]. A study
from the Netherlands also found substantially higher
HIV prevalence amongst TB patients who misused drugs
or were homeless [8]. HIV acquisition by injecting drug
use is a known risk factor for developing TB [9, 10];
however, the interactions between different social risk
factors and HIV infection amongst patients with TB have
not been investigated in the UK.
In the UK, HIV testing is universally recommended in
sexual health clinics, antenatal services, drug depend-
ency programmes and healthcare services for people di-
agnosed with TB, hepatitis B and C, or lymphoma. It is
also recommended as part of routine practice where the
HIV prevalence in the local population exceeds 2 per
1000 and for patients with risk factors for HIV such as
other sexually transmitted infections or high-risk sexual
behaviour [11]. Understanding factors currently associ-
ated with TB-HIV allows us to target screening for both
HIV and latent tuberculosis infection (LTBI) to patients
most at risk of developing TB disease. In this study we
describe temporal trends in HIV infection of TB patients
and identify characteristics of TB patients associated
with HIV, focussing on social risk factors (drug and alco-
hol misuse, homelessness and imprisonment) to deter-
mine whether current British HIV Association (BHIVA)
guidelines on testing for HIV and LTBI remain
appropriate.
Methods
Study population
Statutory notifications of TB cases are reported to Public
Health England (PHE)’s Enhanced TB Surveillance (ETS)
system by clinicians, along with data on the clinical and
sociodemographic characteristics of each TB case. We
conducted a retrospective study of all adult (≥ 15 years)
patients with TB in England, Wales and Northern
Ireland, notified to ETS from 2000 to 2014.
Outcome: HIV status
The national HIV and AIDS Reporting System (HARS)
comprises reports of all new HIV/AIDS diagnoses and
deaths from the HIV and AIDS New Diagnoses Data-
base; annual reporting on all people accessing HIV care
at National Health Service (NHS) sites from the Survey
of Prevalent HIV Infections Diagnosed; and death re-
ports from the Office for National Statistics [12, 13]. As
HARS does not collect unique personal identifiers, ETS
and HARS data were linked to determine the HIV status
of TB patients using a probabilistic matching algorithm
(adapted from [14]), with supplementary deterministic
matching to accept/reject borderline matches [15].
Exposure variables
We included sociodemographic (sex, ethnicity, HIV
prevalence in country of birth, index of multiple
deprivation [IMD] decile and history of drug misuse, al-
cohol misuse, homelessness or imprisonment) and clin-
ical (site(s) of disease, year of TB notification, age at TB
notification) exposure variables.
IMD score deciles represent relative levels of
deprivation of income, employment, health, education,
housing and services, crime and living environment for
small areas in England and Wales, where 1 =most de-
prived and 10 = least deprived [16, 17]. Data on social
risk factors (IMD decile, current alcohol misuse, current
or previous drug misuse, imprisonment or homeless-
ness) were only available from 2010 onwards.
Composite variables were created combining ethnicity
and country of birth due to known interactions. As a
proxy for HIV exposure, countries of birth were grouped
by HIV prevalence; ‘high prevalence’ was defined as >
1% in the adult population living with HIV, as per World
Health Organization (WHO) estimates [18]. Site of TB
disease was categorised into three discrete groups: mil-
iary or meningeal TB (with or without pulmonary
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disease), pulmonary disease with or without other
extra-pulmonary disease (excluding miliary or meningeal
TB) and other extra-pulmonary disease only. Patients
with miliary and meningeal TB have low rates of treat-
ment completion and high rates of death; therefore, we
treated this as a separate category.
Statistical analysis
Data were analysed in Stata version 13.1. Descriptive
analyses of the study population were undertaken, exam-
ining the proportion of people with TB who were in-
fected with HIV and trends over the study period.
Diagnoses were considered ‘simultaneous’ when HIV
and TB diagnoses were made within 91 days of each
other.
To investigate factors associated with HIV infection,
we calculated the proportion of cases with HIV stratified
by exposure variable and estimated odds ratios (ORs)
using univariable logistic regression models. Two multi-
variable models were then built, a ‘whole-population’
model including all cases, and a model including only
cases from 2010 to 2014. Year of TB notification, age at
TB notification, sex, ethnicity and country of birth were
included in both models; data on social risk factors were
only available for 2010 to 2014. Site of TB disease was
not included in the regression models, as it may be an
outcome of HIV co-infection rather than a risk factor.
Linearity (of age group, year and IMD decile) was
assessed using likelihood-ratio tests, and variables were
treated as categorical if P > 0.05. We excluded patients
missing data on one or more variables. To assess the im-
pact of missing data, we compared the distributions of
all demographic factors for cases with missing vs.
complete data. Sensitivity analyses investigated the im-
pact of excluding weaker matches between ETS and
HARS and the impact of excluding year of TB notifica-
tion, as it may have confounded the relationship be-
tween ethnicity/country of birth and HIV status as the
demographics of TB cases in the UK changed over the
study period due to changing migration patterns.
Results
Descriptive epidemiology
There were 106,829 cases of TB in adults (≥ 15 years) re-
ported to ETS in England, Wales and Northern Ireland
for the period 2000–2014. Overall, 5792 patients (5.4%)
were identified as having HIV through record linkage.
There were no substantial differences in HIV prevalence
amongst those with missing data for any variable
(Table 1).
The proportion of TB patients with HIV peaked in
2004 (543/6782, 8.0%, Table 1), although the number
was higher in 2005 (555/7489). This decreased to 205/
6461 (3.2%) in 2014 (Fig. 1). The number of co-infected
patients diagnosed with HIV first rose substantially from
33.5% in 2000 to 57.1% in 2014 (Fig. 2), whilst the num-
ber of cases diagnosed with TB first fell from 22.8% to
4.4%. The number of simultaneous diagnoses peaked at
54.9% in 2004, but has since decreased to 38.5%. This
was largely due to a decline in simultaneous HIV and
TB diagnoses amongst black African people who ac-
quired HIV through heterosexual sex (Additional file 1:
Figure S1 and Additional file 2: Figure S2). HIV testing
at the time of TB diagnosis increased across all ethnic
groups from 2011 to 2014, with the greatest increase oc-
curring in populations with a low prevalence of HIV
(Additional file 3: Table S1).
During the study period, HIV infection was more fre-
quent in women (2935/46,696, 6.3%) than in men (2846/
59,931, 4.7%); however, the decline was larger in women
(Fig. 3). There were also declines in HIV infection in TB
patients aged 15–44, but not in patients aged 45 or older
(Fig. 4).
HIV infection was most frequent in TB patients of
black African ethnicity born in countries with a high
HIV prevalence (3537/10,956, 32.3%), compared to 477/
18,947 (2.5%) in white TB patients born in countries
with low HIV prevalence. Temporal changes in the eth-
nicity of patients with TB (Fig. 5) correlate with overall
trends in the number and percentage of people with TB
and HIV; TB in people of black African ethnicity peaked
in 2006 and has since been decreasing, whereas the
number of Asian patients with TB was increasing until
2011.
Factors associated with HIV infection
Factors associated with HIV infection were consistent
between the univariable and multivariable results
(Table 2). Year and age were included as categorical vari-
ables (tests for linearity both P < 0.001).
Sensitivity analyses investigating the impact of exclud-
ing weaker matches between ETS and HARS, and the
impact of excluding year of TB notification from the
multivariable models, showed results consistent with the
main models (Additional file 3: Tables S2 and S3).
Social risk factors associated with HIV infection
From 2010 to 2014, 37,162 TB cases were notified, and
1393 (3.8%) were infected with HIV. Complete data on
social risk factors (drug and alcohol misuse, homeless-
ness, imprisonment and IMD decile) were available for
30,105 patients (81%).
Compared to TB patients without social risk factors,
HIV was more frequent in people with current or previ-
ous drug misuse (8.1%), homelessness (8.9%), imprison-
ment (6.0%) or alcohol misuse (4.6%) (Table 1). There
was no substantial difference in the year of notification,
age or site of disease for patients with completed social
Winter et al. BMC Medicine  (2018) 16:85 Page 3 of 12
Table 1 The number and percentage of notified tuberculosis cases with and without HIV infection in England, Wales and Northern
Ireland, 2000–2014
Number of TB cases (whole population)
HIV– HIV+ (%) Total
Total 101,037 5792 (5.4%) 106,829
Year
2000 5701 224 (3.8%) 5925
2001 5697 279 (4.7%) 5976
2002 6057 440 (6.8%) 6497
2003 6003 511 (7.8%) 6514
2004 6239 543 (8.0%) 6782
2005 6934 555 (7.4%) 7489
2006 7027 527 (7.0%) 7554
2007 6926 454 (6.2%) 7380
2008 7102 473 (6.2%) 7575
2009 7582 393 (4.9%) 7975
2010 7168 364 (4.8%) 7532
2011 7769 316 (3.9%) 8085
2012 7631 277 (3.5%) 7908
2013 6945 231 (3.2%) 7176
2014 6256 205 (3.2%) 6461
Sex
Female 43,761 2935 (6.3%) 46,696
Male 57,085 2846 (4.7%) 59,931
Missing 191 11 (5.4%) 202
Age group (years)
15–24 16,628 320 (1.9%) 16,948
25–34 28,658 1969 (6.4%) 30,627
35–44 17,521 2281 (11.5%) 19,802
45–54 12,347 872 (6.6%) 13,219
55–64 9283 255 (2.7%) 9538
65+ 16,576 94 (0.6%) 16,670
Missing 24 1 (4.0%) 25
Ethnicity/country of birth
White, low HIV prevalence 18,470 477 (2.5%) 18,947
Black African, low HIV prevalence 7672 249 (3.1%) 7921
Indian sub-continent, low HIV prevalence 38,745 179 (0.5%) 38,924
Other/unknown, low HIV prevalence 8692 197 (2.2%) 8889
White, high HIV prevalence 232 20 (7.9%) 252
Black African, high HIV prevalence 7419 3537 (32.3%) 10,956
Indian sub-continent, high HIV prevalence 1325 29 (2.1%) 1354
Other/unknown, high HIV prevalence 1673 254 (13.2%) 1927
Country of birth unknown 16,809 850 (4.8%) 17,659
Site of TB disease
Pulmonary, +/−extra-pulmonarya 52,770 3227 (5.8%) 55,997
Miliary/meningeal TB 3747 780 (17.2%) 4527
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risk factor data and patients missing data on one or
more social risk factors. However, patients with missing
social risk factor data were more likely to be women
and/or from the Indian sub-continent.
Table 3 shows the percentage of TB patients with
combinations of different risk factors, and the propor-
tion with HIV. There was substantial correlation be-
tween different social risk factors amongst patients with
TB. HIV infection was most frequent amongst TB pa-
tients with a history of drug misuse and homelessness
(11.5% infected). HIV prevalence amongst TB patients
with no history of drug misuse, homelessness or impris-
onment was 3.2%.
In univariable analyses we found positive associations
with HIV infection for homelessness (OR 2.75 [2.20–
3.43]), imprisonment (OR 1.80 [1.38–2.34]), drug misuse
(OR 2.48 [1.98–3.12]) and alcohol misuse (OR 1.38
[1.05–1.82]). The associations for other explanatory vari-
ables were consistent with the whole-population model.
IMD decile was retained as a linear variable (test for lin-
earity P = 0.14). In a multivariable model adjusted for all
variables shown in Table 1, the only social risk factor
Table 1 The number and percentage of notified tuberculosis cases with and without HIV infection in England, Wales and Northern
Ireland, 2000–2014 (Continued)
Number of TB cases (whole population)
HIV– HIV+ (%) Total
Extra-pulmonary only 44,218 1761 (3.8%) 45,979
Missing 302 24 (7.4%) 326
Homelessnessb
No 32,129 1136 (3.4%) 33,265
Yes 947 92 (8.9%) 1039
Missing 2693 165 (5.8%) 2858
Imprisonmentb
No 31,092 1102 (3.4%) 32,194
Yes 958 61 (6.0%) 1019
Missing 3719 230 (5.8%) 3949
Drug misuseb
No 31,823 1125 (3.4%) 32,948
Yes 980 86 (8.1%) 1066
Missing 2966 182 (5.8%) 3148
Alcohol misuseb
No 31,297 1098 (3.4%) 32,395
Yes 1134 55 (4.6%) 1189
Missing 3338 240 (6.7%) 3578
IMD decileb
1 7547 350 (4.4%) 7897
2 6836 287 (4.0%) 7123
3 5531 218 (3.8%) 5749
4 4207 134 (3.1%) 4341
5 3050 112 (3.5%) 3162
6 2294 89 (3.7%) 2383
7 1669 61 (3.5%) 1730
8 1408 48 (3.3%) 1456
9 1228 45 (3.5%) 1273
10 994 19 (1.9%) 1013
Missing 1005 30 (2.9%) 1035
aExcluding miliary and meningeal tuberculosis
b2010–2014 only
IMD index of multiple deprivation, TB tuberculosis
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with strong statistical evidence for an association with
HIV infection was drug misuse (OR 2.70 [1.90–3.84], P
< 0.001). There was no evidence for statistical interac-
tions between the social risk factors in the regression
model (P > 0.25 for all combinations).
Discussion
In this retrospective study of notified TB cases in Eng-
land, Wales and Northern Ireland, we report a substan-
tial decline in both the number and proportion of TB
cases with HIV since 2005 and 2004 respectively, par-
ticularly in women. HIV infection was most frequent
amongst people of black African ethnicity born in
countries with a high HIV prevalence. Drug misuse was
the only social risk factor independently associated with
HIV infection.
Implications of our findings
The proportion of TB cases diagnosed > 91 days after an
HIV diagnosis rose during the study period, whilst the
proportion diagnosed before HIV diagnosis decreased.
This is probably the result of increased HIV testing, earl-
ier HIV diagnoses and a healthier population of PLHIV
due to initiation of anti-retroviral therapy (ART) [19].
The BHIVA and the National Institute of Health and
Care Excellence (NICE) have recommended HIV testing
Fig. 1 The number and proportion of notified tuberculosis cases with and without HIV in England, Wales and Northern Ireland, 2000–2014
Fig. 2 The relationship between the timing of HIV and tuberculosis diagnoses in patients diagnosed with HIV and tuberculosis between 2000
and 2014
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for all patients diagnosed with TB since 2011 [11, 20].
Between 2011 and 2015 more than 90% of TB patients
with previously unknown HIV status were tested for
HIV [1]. However, a substantial proportion of patients
(38.5% in 2014) were diagnosed simultaneously with TB
and HIV. Routine testing of new TB patients for HIV
provides no opportunity to prevent TB disease, and
these TB cases may have been preventable if HIV had
been diagnosed earlier and patients had initiated ART
sooner or been treated for LTBI. In 2008, BHIVA intro-
duced specific guidelines recommending more HIV test-
ing in populations at high risk of infection, and
increased the CD4 count threshold at which they recom-
mend PLHIV start ART. This is reflected in the rise in
median CD4 count representing a healthier population
of PLHIV [19], contributing to the observed decline in
infections. Since 2015, BHIVA guidelines recommend
ART for all PLHIV regardless of their CD4 count, which
should further decrease TB incidence in PLHIV. More
community HIV testing in populations at risk for TB is
necessary to diagnose HIV sooner, to enable previously
undiagnosed PLHIV to begin ART and prevent progres-
sion of LTBI to active disease.
The majority of TB-HIV now occurs in people who
were already known to have HIV and subsequently de-
veloped TB. This has important implications for TB pre-
vention strategies. Focussing on HIV testing and ART
initiation is insufficient to prevent TB in PLHIV, and
Fig. 3 The percentage of notified tuberculosis cases with HIV by sex HIV in England, Wales and Northern Ireland, 2000–2014
Fig. 4 The percentage of notified tuberculosis cases with HIV by age in England, Wales and Northern Ireland, 2000–2014
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increasing testing and treatment of LTBI may further re-
duce TB-HIV. Our data indicate that people of black Af-
rican ethnicity still have high rates of HIV-associated
TB, and that the BHIVA guidelines recommending LTBI
screening in this population of PLHIV remain
appropriate.
Part of the decline in HIV infection can be attributed
to changing migration patterns, resulting in less TB in
black African individuals from countries with a high
HIV prevalence and more amongst individuals from
Asian countries with low HIV prevalence [5]. Whilst the
largest decreases in HIV infection were in black African
TB patients, they remain the most at-risk population.
HIV infection was greater amongst women with TB than
men. This reflects the gender ratio of heterosexual
PLHIV in the UK, where there are more women diag-
nosed with HIV than men, particularly amongst black
Africans [2]. This is likely because of higher diagnostic
rates in women [2] due to antenatal HIV testing; thus,
the decline reflects both the changes in ethnicity of TB
patients and the healthier cohort of women with HIV.
HIV infection declined in patients with TB aged 15–44,
but not in older people. This may be due to the ageing
cohort of PLHIV and the higher rates of late HIV diag-
nosis in older patients, increasing the risk of TB [2].
HIV infection was more frequent in TB patients with
any social risk factor (drug and alcohol misuse, impris-
onment and homelessness) than in those without, and
overall even more frequent amongst TB patients with
multiple social risk factors. However, after adjusting for
other social risk factors in the multivariable model, only
drug misuse remained associated with greater odds of
HIV infection; this is probably the result of HIV acquisi-
tion from injecting drug use. As TB incidence amongst
PLHIV who inject drugs is comparable to that amongst
black Africans from countries with high TB burden [10],
we suggest that LTBI screening and preventive TB ther-
apy for PLHIV with social risk factors, particularly drug
misuse, could decrease TB in this population.
We found a much greater proportion of HIV
co-infection amongst patients with miliary and menin-
geal TB than pulmonary TB, and a lower proportion
amongst patients with other extra-pulmonary disease.
This was consistent over the study period and with pre-
vious work [21], probably because extra-pulmonary TB
is common in patients with TB from the Indian
Fig. 5 The number (a) and percentage (b) of notified tuberculosis cases with HIV by ethnicity in England, Wales and Northern Ireland, 2000–2014
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Table 2 Results from univariable and two multivariable logistic regression models of factors associated with HIV infection in notified
tuberculosis cases in England, Wales and Northern Ireland, for the periods 2000–2014 and 2010–2014
Univariable results (whole
population)
Multivariable results (whole
population)
Multivariable results (2010–
2014)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Year
2000 1.00 < 0.001 1.00 < 0.001 –
2001 1.25 (1.04–1.49) 1.22 (1.00–1.48) –
2002 1.85 (1.57–2.18) 1.45 (1.20–1.74) –
2003 2.17 (1.84–2.55) 1.51 (1.26–1.80) –
2004 2.22 (1.89–2.60) 1.56 (1.31–1.87) –
2005 2.04 (1.74-–2.39) 1.40 (1.17–1.67) –
2006 1.91 (1.63–2.24) 1.36 (1.14–1.62) –
2007 1.67 (1.42–1.97) 1.22 (1.01–1.46) –
2008 1.70 (1.44–1.99) 1.25 (1.04–1.50) –
2009 1.32 (1.12–1.56) 1.04 (0.86–1.25) –
2010 1.29 (1.09–1.53) 1.06 (0.87–1.28) 1.00 < 0.001
2011 1.04 (0.87–1.23) 0.83 (0.68–1.01) 0.76 (0.61–0.93)
2012 0.92 (0.77–1.11) 0.82 (0.67–1.00) 0.81 (0.65–0.99)
2013 0.85 (0.70–1.02) 0.76 (0.62–0.94) 0.66 (0.53–0.83)
2014 0.83 (0.69–1.01) 0.72 (0.58–0.89) 0.68 (0.54–0.85)
Sex
Female 1.00 < 0.001 1.00 < 0.001 1.00 0.03
Male 0.74 (0.70–0.78) 0.84 (0.79–0.90) 0.85 (0.74–0.98)
Age group (years)
15–24 0.28 (0.25–0.32) < 0.001 0.28 (0.24–0.32) < 0.001 0.31 (0.22–0.44) < 0.001
25–34 1.00 1.00 1.00
35–44 1.89 (1.78–2.02) 1.97 (1.83–2.13) 2.16 (1.79–2.59)
45–54 1.03 (0.95–1.12) 1.33 (1.21–1.47) 1.97 (1.60–2.44)
55–64 0.40 (0.35–0.46) 0.62 (0.54–0.72) 1.35 (1.02–1.78)
65+ 0.08 (0.07–0.10) 0.16 (0.13–0.19) 0.31 (0.20–0.49)
Ethnicity/country of birth
White, low HIV prevalence 1.00 < 0.001 1.00 < 0.001 1.00 < 0.001
Black African, low HIV prevalence 1.26 (1.08–1.47) 1.07 (0.91–1.26) 1.07 (0.74–1.55)
Indian sub-continent, low HIV prevalence 0.18 (0.15–0.21) 0.16 (0.14–0.20) 0.20 (0.14–0.28)
Other/unknown, low HIV prevalence 0.88 (0.74–1.04) 0.73 (0.62–0.87) 0.67 (0.46–0.96)
White, high HIV prevalence 3.34 (2.10–5.32) 2.43 (1.51–3.91) 3.85 (1.45–10.23)
Black African, high HIV prevalence 18.46 (16.71–20.39) 13.02 (11.69–14.50) 10.39 (8.13–13.29)
Indian sub-continent, high HIV prevalence 0.85 (0.58–1.24) 0.69 (0.47–1.01) 0.51 (0.20–1.26)
Other/unknown, high HIV prevalence 5.88 (5.01–6.90) 4.56 (3.85–5.39) 4.07 (2.79–5.94)
Country of birth unknown 1.96 (1.75–2.19) 1.62 (1.44–1.82) 1.51 (1.14–2.00)
Site of TB disease
Pulmonary, +/−extra-pulmonarya 1.00 < 0.001 1.00 < 0.001 1.00 < 0.001
Miliary/meningeal TB 3.40 (3.13–3.71) 3.30 (2.96–3.68) 3.81 (3.02–4.80)
Extra-pulmonary only 0.65 (0.61–0.69) 0.70 (0.65–0.75) 0.73 (0.63–0.86)
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sub-continent [21] where HIV prevalence is low. Our re-
sults were consistent with other studies reporting higher
prevalence of HIV co-infection amongst cases of miliary
[22] and meningeal [23] TB, and lower HIV prevalence
amongst other forms of extra-pulmonary TB. Recent
work in the UK showed that patients with severe
extra-pulmonary TB have worse outcomes than those
with pulmonary TB, whilst patients with other
extra-pulmonary TB generally have better outcomes [1].
It is unclear whether this is solely because of severe dis-
ease presentation or whether these patients could be in-
fluenced by higher rates of HIV co-infection (and
corresponding clinical complexity). Regardless, as diag-
nosis of extra-pulmonary TB is often difficult, increasing
awareness of extra-pulmonary TB symptoms amongst
PLHIV and populations with high rates of undiagnosed
HIV might allow earlier diagnosis of extra-pulmonary TB.
Strengths and limitations
This study benefits from 15 years of case notifications to
robust national surveillance programmes, representing
comprehensive coverage of TB cases in England, Wales
and Northern Ireland. However, there are some limita-
tions. The HIV surveillance dataset does not contain
Table 2 Results from univariable and two multivariable logistic regression models of factors associated with HIV infection in notified
tuberculosis cases in England, Wales and Northern Ireland, for the periods 2000–2014 and 2010–2014 (Continued)
Univariable results (whole
population)
Multivariable results (whole
population)
Multivariable results (2010–
2014)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Homelessness
No 1.00 < 0.001 – 1.00 0.26
Yes 2.75 (2.20–3.43) – 1.22 (0.87–1.72)
Imprisonment
No 1.00 < 0.001 – 1.00 0.19
Yes 1.80 (1.38–2.34) – 0.77 (0.52–1.15)
Drug misuse
No 1.00 < 0.001 – 1.00 < 0.001
Yes 2.48 (1.98–3.12) – 2.70 (1.90–3.84)
Alcohol misuse
No 1.00 0.03 – 1.00 0.73
Yes 1.38 (1.05–1.82) – 0.93 (0.64–1.37)
IMD decile
(for each unit increase) 0.95 (0.93–0.97) < 0.001 – 0.99 (0.96–1.02) 0.47
aExcluding miliary and meningeal TB. CI confidence interval, IMD index of multiple deprivation, OR odds ratio, TB tuberculosis
The whole-population model excluded 226 (0.2%) TB cases missing data on sex (n = 202) and/or age (n = 25), and was adjusted for year of TB notification, age, sex
and ethnicity and HIV prevalence in country of birth. The 2010–2014 model excluded 7098 (19%) TB cases missing data on sex (n = 60), homelessness (n = 2693),
imprisonment (n = 3719), drug misuse (n = 2966), alcohol misuse (n = 3338) and/or IMD decile (n = 1035) and adjusted for all variables in the table
Table 3 The number of notified tuberculosis cases with and without a history of drug misuse, homelessness or imprisonment, and
the HIV prevalence in each of these groups in England, Wales and Northern Ireland, 2000–2014
Drug misuse Total
No Yes
Total (homeless and not homeless, number) No prison 30,711 (3.2% [3.1–3.4]) 506 (8.3% [5.9–10.7]) 31,217 (3.3% [3.1–3.5])
(% with HIV [95% CI]) Prison 480 (4.4% [2.5–6.2]) 365 (6.8% [4.3–9.4]) 845 (5.4% [3.9–7.0])
Total 31,191 (3.3% [3.1–3.5]) 871 (7.7% [5.9–9.5]) 32,062 (3.4% [3.2–3.6])
Homeless (number) No prison 465 (7.1% [4.8–9.4]) 86 (14.0% [6.6–21.3]) 551 (8.2% [5.9–10.5])
(% with HIV [95% CI]) Prison 99 (3.0% [0.4–6.4]) 149 (10.1% [5.2–14.9]) 248 (7.3% [4.0–10.5])
Total 564 (6.4% [4.4–8.4]) 235 (11.5% [7.4–15.6]) 799 (7.9% [6.0–9.8])
Not homeless (number) No prison 30,246 (3.2% [3.0–3.4]) 420 (7.1% [4.7–9.6]) 30,666 (3.2% [3.0–3.4])
(% with HIV [95% CI]) Prison 381 (4.7% [2.6–6.9]) 216 (4.6% [1.8–7.4]) 597 (4.7% [3.0–6.4])
Total 30,627 (3.2% [3.0–3.4]) 636 (6.3% [4.4–8.2]) 31,263 (3.3% [3.1–3.5])
Excluding 5899 (16%) cases missing data on homelessness (n = 2693), imprisonment (n = 3719) and/or drug misuse (n = 2966)
CI confidence interval
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personally identifiable information (PII), meaning that
record linkage to the TB data was necessary. The prob-
abilistic algorithm we adapted has very high sensitivity
(97.1%) and specificity (100.0%), even when PII such as
NHS numbers and addresses are not available [14]. To
reduce bias, we adapted the algorithm, removing the
need for subjective manual review of borderline matches
by replacing this step with deterministic record linkage
[15]. The record linkage algorithm used ethnicity, year
and country of birth to link cases, and although the
completeness of these variables was high (Table 1), cases
missing these variables (in either dataset) were less likely
to be linked. It is therefore possible that we underesti-
mated the prevalence of TB-HIV if we could not link
some records due to missing data. We conducted sensi-
tivity analyses, excluding weaker matches between TB
and HIV records to assess whether risk factors differed
for patients about whose HIV status we were less certain.
These provided consistent results, suggesting that the
matching algorithm did not affect our conclusions. Ro-
bust, high-quality national disease surveillance databases
are essential for monitoring progress towards the
WHO’s sustainable development goals. Both the TB and
HIV surveillance systems in the UK are of very high
quality, but the inclusion of HIV status in the TB surveil-
lance system, or the ability to link the two datasets using
unique patient identifiers, would be beneficial for future
research.
Most variables had little missing data; however, 19% of
patients from 2010 to 2014 were missing some social
risk factor data. These patients were more likely to be
women or from the Indian sub-continent; both groups
had low levels of social risk factors [1]. Consequently, any
bias in our results will be towards the null, underestimat-
ing the association between TB and social risk factors.
We were only able to identify infected individuals with
diagnosed HIV, and an estimated 13% of HIV infections
were undiagnosed in 2015 [2]. However, 94% of people
diagnosed with TB in 2015 received HIV testing or were
already aware of their HIV status [1], and therefore we
would expect very low prevalence of undiagnosed HIV
in this population. There may be more undiagnosed HIV
amongst patients prior to 2011, when testing TB patients
for HIV became routine; however, most of these patients
would have since presented to care and been linked in
our dataset. As this was a retrospective, observational
study of TB cases, we could not establish causality be-
tween HIV infection and TB disease, but it is likely that
HIV infection precedes TB disease. Our study demon-
strates a continuing risk of infection with HIV amongst
patients with TB, supporting the guidance for universal
HIV testing for all patients diagnosed with TB and
highlighting the groups that should be prioritised for in-
terventions that improve testing uptake.
Conclusions
TB-HIV infection has substantially decreased over the
past decade in England, Wales and Northern Ireland, as
has the proportion of patients diagnosed simultaneously
with both infections. However, sub-populations of pa-
tients with high rates of infection remain. Whilst the
current policy of testing all patients diagnosed with TB
for HIV infection is important in ensuring appropriate
management of TB patients, many of these TB cases
would be preventable if HIV could be diagnosed before
TB develops. Increasing HIV testing and ensuring early
treatment of HIV infection in black African populations
(particularly people born in countries with high HIV
prevalence) and people with a history of drug misuse
could help prevent these TB cases. The BHIVA guide-
lines on LTBI testing for PLHIV from sub-Saharan Af-
rica remain relevant, and LTBI screening for PLHIV
with a history of drug misuse, homelessness or impris-
onment should also be considered.
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